Skip to main content
. Author manuscript; available in PMC: 2014 Sep 10.
Published in final edited form as: J Thorac Oncol. 2013 Jul;8(7):823–859. doi: 10.1097/JTO.0b013e318290868f

TABLE 4.

EGFR Mutation Prevalence in Different Lung Adenocarcinoma Patient Populationsa

EGFR Mutation Prevalence, % EGFR Mutation Positive EGFR Mutation Negative n (N)
Asian/Pacificb 45 1547 1905 31 (3452)
Whitec 24 853 2681 10 (3534)
African Americand 20 19 78 3 (97)
Hispanice 17 65 307 4 (372)
Asian/Indianf 52 114 106 1 (220)

Abbreviations: n, number of studies; N, number of patients.

a

Data for other populations were absent or too limited for analysis.

b

References 7, 17, 32, 35, 48, 49, 55, 133, 184, 185, 191, 257, 264, 269, 270, 272276, 278, 283292.

c

References 17, 32, 191, 192, 253, 273, 288, 292294

d

References 256, 288, 293

e

References 128, 254, 267, 288

f

Reference 295.

HHS Vulnerability Disclosure